Athos Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Athos Capital's ONCE Position: Q4 2019 in Review
Athos Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 22,139 shares — an estimated $2.15M sold.
Athos Capital first reported a position in ONCE in Q2 2019 and held it in 2 quarters. The position peaked at $2.17M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Athos Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Athos Capital sold 22,139 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.15M.
- Athos Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
- Athos Capital's Spark Therapeutics, Inc. Common Stock position peaked at $2.17M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Athos Capital's 13F filing for Q4 2019, filed 11 Feb 2020.